Evidence map›Paper›PMID 29062084›Full record

ArticleScientific reports2017

Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.

Mehrdad Pazhouhandeh, Fatemeh Samiee, Tahereh Boniadi, Abbas Fadaei Khedmat, Ensieh Vahedi, Mahsa Mirdamadi, Naseh Sigari, Seyed Davar Siadat, Farzam Vaziri, Abolfazl Fateh and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Noncoding Microdeletion in MouseThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Mehrdad PazhouhandehHuman Antibody Lab, Innovation Center, Pasteur Institute of Iran, Tehran, Iran.
Fatemeh SamieeDepartment of Microbial Biotechnology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran.
Tahereh BoniadiDepartment of Microbial Biotechnology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran.
Abbas Fadaei KhedmatDepartment of Pulmonology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ensieh VahediChemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mahsa MirdamadiRajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Naseh SigariInternal Medicine Department, Medical Faculty, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Seyed Davar SiadatHuman Antibody Lab, Innovation Center, Pasteur Institute of Iran, Tehran, Iran.
Farzam VaziriHuman Antibody Lab, Innovation Center, Pasteur Institute of Iran, Tehran, Iran.
Abolfazl FatehHuman Antibody Lab, Innovation Center, Pasteur Institute of Iran, Tehran, Iran.
Faezeh AjorlooDepartment of Biology, Faculty of Science, Islamic Azad University, East Tehran Branch, Tehran, Iran.
Elham TafsiriMolecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Mostafa GhaneiChemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. m.ghanei@bmsu.ac.ir.
Fereidoun MahboudiBiotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Fatemeh Rahimi JamnaniHuman Antibody Lab, Innovation Center, Pasteur Institute of Iran, Tehran, Iran. Rahimi@pasteur.ac.ir.
Pasteur Institute of Iran · IRBaqiyatallah University of Medical Sciences · IRIslamic Azad University Pharmaceutical Sciences Branch · IRBiotechnology Research Center · IRIslamic Azad University South Tehran Branch · IRKurdistan University of Medical Sciences · IRShaheed Rajaei Cardiovascular Medical and Research Center · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cigarette smoking is the leading cause of lung cancer worldwide. In this study, we evaluated the serum autoantibody (AAb) repertoires of non-small cell lung cancer (NSCLC) patients and smokers (SM), leading to the identification of overactivated pathways and hubs involved in the pathogenesis of NSCLC. Surface- and solution-phase biopanning were performed on immunoglobulin G purified from the sera of NSCLC and SM groups. In total, 20 NSCLC- and 12 SM-specific peptides were detected, which were used to generate NSCLC and SM protein datasets. NSCLC- and SM-related proteins were visualized using STRING and Gephi, and their modules were analyzed using Enrichr. By integrating the overrepresented pathways such as pathways in cancer, epithelial growth factor receptor, c-Met, interleukin-4 (IL-4) and IL-6 signaling pathways, along with a set of proteins (e.g. phospholipase D (PLD), IL-4 receptor, IL-17 receptor, laminins, collagens, and mucins) into the PLD pathway and inflammatory cytokines network as the most critical events in both groups, two super networks were made to elucidate new aspects of NSCLC pathogenesis and to determine the influence of cigarette smoking on tumour formation. Taken together, assessment of the AAb repertoires using a systems biology approach can delineate the hidden events involved in various disorders.

Indexed as

Gene Regulatory NetworksAdenocarcinomaAdolescentAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCase-Control StudiesChildFemaleFollow-Up StudiesGene OntologyHumansLung NeoplasmsBiomarkers, Tumor

Identifiers

PMID29062084
PMCPMC5653836
OpenAlexW2767075144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.